CN111989091A - 含有树脂颗粒的药物组合物 - Google Patents
含有树脂颗粒的药物组合物 Download PDFInfo
- Publication number
- CN111989091A CN111989091A CN201880088993.9A CN201880088993A CN111989091A CN 111989091 A CN111989091 A CN 111989091A CN 201880088993 A CN201880088993 A CN 201880088993A CN 111989091 A CN111989091 A CN 111989091A
- Authority
- CN
- China
- Prior art keywords
- exchange resin
- ion exchange
- weight
- particles
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (9)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762609701P | 2017-12-22 | 2017-12-22 | |
US62/609701 | 2017-12-22 | ||
US201862637429P | 2018-03-02 | 2018-03-02 | |
US62/637429 | 2018-03-02 | ||
PCT/US2018/066497 WO2019126321A1 (en) | 2017-12-22 | 2018-12-19 | Pharmaceutical composition containing resin particles |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111989091A true CN111989091A (zh) | 2020-11-24 |
Family
ID=65024061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880088993.9A Pending CN111989091A (zh) | 2017-12-22 | 2018-12-19 | 含有树脂颗粒的药物组合物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210077402A1 (zh) |
EP (1) | EP3727339A1 (zh) |
KR (1) | KR20200117999A (zh) |
CN (1) | CN111989091A (zh) |
CA (1) | CA3088720A1 (zh) |
WO (1) | WO2019126321A1 (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA656643A (en) * | 1963-01-29 | Wallace And Tiernan Inc. | Pharmaceutical preparation containing resin narcotic compound | |
EP0367746A2 (en) * | 1988-11-02 | 1990-05-09 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
US20060115529A1 (en) * | 2003-05-07 | 2006-06-01 | Seonghoon Jeong | Fast-melting tablets having taste-masking and sustained release properties |
CN102488652A (zh) * | 2006-03-16 | 2012-06-13 | 特瑞斯制药股份有限公司 | 含有药物-离子交换树脂复合物的经修饰释放的制剂 |
US20130071476A1 (en) * | 2011-08-19 | 2013-03-21 | Subraman Rao Cherukuri | Rapid Melt Controlled Release Taste-Masked Compositions |
CN103517708A (zh) * | 2011-04-06 | 2014-01-15 | 科翟特蔻·布瑞克茨克 | 药物组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8343546B2 (en) | 2005-09-13 | 2013-01-01 | Coating Place, Inc. | Ion exchange resin treated to control swelling |
-
2018
- 2018-12-19 WO PCT/US2018/066497 patent/WO2019126321A1/en unknown
- 2018-12-19 US US16/954,362 patent/US20210077402A1/en not_active Abandoned
- 2018-12-19 KR KR1020207020463A patent/KR20200117999A/ko active Search and Examination
- 2018-12-19 EP EP18834176.2A patent/EP3727339A1/en not_active Withdrawn
- 2018-12-19 CN CN201880088993.9A patent/CN111989091A/zh active Pending
- 2018-12-19 CA CA3088720A patent/CA3088720A1/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA656643A (en) * | 1963-01-29 | Wallace And Tiernan Inc. | Pharmaceutical preparation containing resin narcotic compound | |
EP0367746A2 (en) * | 1988-11-02 | 1990-05-09 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
US20060115529A1 (en) * | 2003-05-07 | 2006-06-01 | Seonghoon Jeong | Fast-melting tablets having taste-masking and sustained release properties |
US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
CN102488652A (zh) * | 2006-03-16 | 2012-06-13 | 特瑞斯制药股份有限公司 | 含有药物-离子交换树脂复合物的经修饰释放的制剂 |
CN103517708A (zh) * | 2011-04-06 | 2014-01-15 | 科翟特蔻·布瑞克茨克 | 药物组合物 |
US20130071476A1 (en) * | 2011-08-19 | 2013-03-21 | Subraman Rao Cherukuri | Rapid Melt Controlled Release Taste-Masked Compositions |
Non-Patent Citations (1)
Title |
---|
EVA ROBLEGG等: "Reformulation of a codeine phosphate liquid controlled-release product", 《DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY》 * |
Also Published As
Publication number | Publication date |
---|---|
CA3088720A1 (en) | 2019-06-27 |
KR20200117999A (ko) | 2020-10-14 |
US20210077402A1 (en) | 2021-03-18 |
EP3727339A1 (en) | 2020-10-28 |
WO2019126321A1 (en) | 2019-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2256442C2 (ru) | Потребляемая пленка, предназначенная для держания во рту, и способ получения потребляемой пленки | |
EP0294103B1 (en) | A sustained-release preparation and production thereof | |
US4539199A (en) | Sustained release pharmaceutical compositions | |
US8202542B1 (en) | Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings | |
RU2501569C2 (ru) | Фармацевтическая композиция, содержащая алкалоиды, резистентная к рекреационным злоупотреблениям (варианты), и способ ее получения, способ приема фармацевтической субстанции, содержащей алкалоиды, теплокровным существом, добавка для предотвращения рекреационных злоупотреблений фармацевтической субстанцией, содержащей алкалоиды, и способ ее получения | |
JP2002534374A (ja) | 多粒子経口用量形態 | |
DK160601B (da) | Farmaceutisk harpiksholdigt, sustained release praeparat med kontrolleret afgivelse af et farmaceutisk acceptabelt syreadditionssalt af dextromethorphan samt fremgangsmaade til fremstilling deraf | |
WO1998027961A2 (en) | Antitussive drugs delivered by partially coated ion exchange resins | |
CA2554640C (en) | Pharmaceutical composition for oral application and method for preparing thereof | |
WO2013119231A1 (en) | Abuse resistant opioid drug - ion exchange resin complexes having hybrid coatings | |
KR20170016955A (ko) | 트레프로스티닐 제제 | |
EP1898913A1 (en) | Multiple active drug-resin conjugate | |
CN111989091A (zh) | 含有树脂颗粒的药物组合物 | |
CN111971029A (zh) | 含有交联的离子交换树脂的药物组合物 | |
US11602507B2 (en) | Extended release oral composition of memantine or its salt and its process for the preparation | |
Kaushik et al. | Ion exchange resin complexation technique for pharmaceutical taste masking: An overview | |
Mahore et al. | Formulation and in-vitro evaluation of taste masked orodispersible tablet of metoclopramide hydrochloride | |
CN115260355A (zh) | 一种阴离子交换树脂、其制备方法、该树脂与药物的复合物和其掩味制剂 | |
Jadhav et al. | Ion exchange resins: a novel way to solve formulation problems | |
CN111629758A (zh) | 药物树脂化物组合物及其制备和使用方法 | |
JPH09157158A (ja) | 生薬配合製剤 | |
Bhoyar et al. | Formulation and Evaluation of Taste Masked Sustained Release Dosage Form of Metformin Hydrochloride Using Indion Resin | |
CA1096308A (en) | Process for the preparation of pharmaceutical compositions with prolonged effects | |
KR20210008705A (ko) | 몬테루카스트 또는 이의 약학적으로 허용가능한 염을 포함하는 액상 시럽제제 및 이의 제조방법 | |
CN106265666A (zh) | 提高难溶性药物氯雷他定释放度的组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Pennsylvania, America Applicant after: DDP special electronic materials USA Co.,Ltd. Applicant after: DDP special electronic materials eighth Co.,Ltd. Address before: Pennsylvania, America Applicant before: DDP special electronic materials American Co. Applicant before: DDP special electronic materials eighth Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Delaware Applicant after: DDP special electronic materials USA Co.,Ltd. Applicant after: DDP special electronic materials eighth Co.,Ltd. Address before: Pennsylvania, America Applicant before: DDP special electronic materials USA Co.,Ltd. Applicant before: DDP special electronic materials eighth Co.,Ltd. |
|
CB02 | Change of applicant information |